Skip to main content
SpringerLink
Log in

How to revascularize patients with diabetes mellitus—

Bypass or stents and drugs?

  • CLINICAL PERSPECTIVE
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Summary

The diabetic patient is at high risk for coronary artery disease. Incidence as well as severity of the disease is highly increased in comparison to non–diabetic patients. The revascularization of the diabetic patient is a great challenge, since the longterm results are disappointing when compared to non–diabetic patients. The success of coronary artery bypass grafting is limited by increased perioperative mortality and a faster occlusion of especially venous bypass grafts. In percutaneous interventions the excessive high restenosis rates worsen longterm results. Several clinical trials investigated the outcome of the two revascularization strategies and could demonstrate at least a tendency towards better results when the operative approach was chosen. Particularily, the BARI trial showed reduced mortality for surgery when compared to percutaneous coronary interventions. However, in this trial, in 87% of patients undergoing bypass surgery all stenoses were succesfully treated, whereas in patients undergoing percutaneous coronary intervention only 76% of all stenoses were primarily succesfully treated. In addition, no stents were used in this trial.

Furthermore, the enrollment of the previous trials dates one decade ago. These trials do therefore not necessarily represent the current standard therapy, especially for percutaneous coronary interventions. The restenosis rate could be decreased in recent years by means of drug–eluting stents and an aggressive antiplatelet therapy from more than 50% to less than 10% leading to considerably improved long–term results. Therefore, percutaneous coronary interventions have developed to be a reasonable alternative to bypass surgery. Different clinical trials are currently underway (BARI 2D, CarDIA, FREEDOM) comparing the outcome of the two approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) (1996) CAPRIE Steering Committee. Lancet 348(9038):1329–1339

    Google Scholar 

  2. Randomised placebo–controlled and balloon–angioplasty–controlled trial to assess safety of coronary stenting with use of platelet glycoprotein–IIb/ IIIa blockade (1998) The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 352(9122):87–92

    Google Scholar 

  3. Seven–year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status (2000) J Am Coll Cardiol 35(5):1122–1129

    Google Scholar 

  4. Aronson D, Bloomgarden Z, Rayfield EJ (1996) Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 27(3):528–535

    Article  CAS  PubMed  Google Scholar 

  5. Barsness GW, Peterson ED, Ohman EM, Nelson CL, DeLong ER, Reves JG, Smith PK, Anderson RD, Jones RH, Mark DB, Califf RM (1997) Relationship between diabetes mellitus and long–term survival after coronary bypass and angioplasty. Circulation 96(8):2551–2556

    CAS  PubMed  Google Scholar 

  6. Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ (2001) Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 103(3):363–368

    CAS  PubMed  Google Scholar 

  7. Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ (2002) Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 90(6):625–628

    Article  PubMed  Google Scholar 

  8. Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ (2000) Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 35(4):922–928

    Article  CAS  PubMed  Google Scholar 

  9. Biondi–Zoccai GG, Abbate A, Liuzzo G, Biasucci LM (2003) Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 41(7):1071–1077

    CAS  PubMed  Google Scholar 

  10. Boeken U, Feindt P, Litmathe J, Gams E (2004) Comparison of complete and incomplete revascularization in CABG–patients with severely impaired left ventricular function (LVF). Z Kardiol 93(3):216–221

    Article  CAS  PubMed  Google Scholar 

  11. Bonow RO, Gheorghiade M (2004) The diabetes epidemic: a national and global crisis. Am J Med 116(Suppl 5A):2S–10S

    Article  PubMed  Google Scholar 

  12. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, Thompson TJ (2001) Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care 24(11):1936–1940

    CAS  PubMed  Google Scholar 

  13. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH (2002) Diabetes mellitus increases short–term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40(3):418–423

    Article  PubMed  Google Scholar 

  14. Creager MA, Luscher T, Cosentino F, Beckman JA (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108(12):1527–1532

    Article  PubMed  Google Scholar 

  15. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schomig A (2005) Paclitaxel–eluting or sirolimuseluting stents to prevent restenosis in diabetic patients. N Engl J Med 353(7):663–670

    Article  CAS  PubMed  Google Scholar 

  16. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulak TA, Antman EM, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP (2004) ACC/ AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 44(5):1146–1154

    Article  Google Scholar 

  17. Eckel RH, Wassef M, Chait A, Sobel B, Barrett E, King G, Lopes–Virella M, Reusch J, Ruderman N, Steiner G, Vlassara H (2002) Prevention conference VI: diabetes and cardiovascular disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation 105(18):e138–e143

    Article  PubMed  Google Scholar 

  18. Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, Neumann FJ, Schomig A (1998) Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32(7):1866–1873

    Article  CAS  PubMed  Google Scholar 

  19. Endo M, Tomizawa Y Nishida H (2003) Bilateral versus unilateral internal mammary revascularization in patients with diabetes. Circulation 108 (11):1343–1349

    Article  PubMed  Google Scholar 

  20. Finn AV, Palacios IF, Kastrati A, Gold HK (2005) Drug–eluting stents for diabetes mellitus: a rush to judgment? J Am Coll Cardiol 45(4):479–483

    Article  CAS  PubMed  Google Scholar 

  21. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339(4):229–234

    Article  CAS  PubMed  Google Scholar 

  22. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W (1994) A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 331(16):1037–1043

    CAS  PubMed  Google Scholar 

  23. Hammoud T, Tanguay JF, Bourassa MG (2000) Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 36(2):355–365

    Article  CAS  PubMed  Google Scholar 

  24. Kastrati A, Dibra A, Eberle S, Mehilli J, Suarez de Lezo J, Goy JJ, Ulm K, Schomig A (2005) Sirolimus–eluting stents vs paclitaxel–eluting stents in patients with coronary artery disease: meta–analysis of randomized trials. JAMA 294(7):819–825

    Article  CAS  PubMed  Google Scholar 

  25. Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schuhlen H, Neumann FJ, Fleckenstein M, Pfafferott C, Seyfarth M, Schomig A (2001) Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR–STEREO) trial. Circulation 103(23):2816–2821

    CAS  PubMed  Google Scholar 

  26. King SB 3rd, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS (2000) Eightyear mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol 35(5):1116–1121

    PubMed  Google Scholar 

  27. Kornowski R, Mintz GS, Lansky AJ, Hong MK, Kent KM, Pichard AD, Satler LF, Popma JJ, Bucher TA, Leon MB (1998) Paradoxic decreases in atherosclerotic plaque mass in insulintreated diabetic patients. Am J Cardiol 81(11):1298–1304

    Article  CAS  PubMed  Google Scholar 

  28. Kurbaan AS, Bowker TJ, Ilsley CD, Sigwart U, Rickards AF (2001) Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am J Cardiol 87(8):947–950; A3

    Article  CAS  PubMed  Google Scholar 

  29. Lau KW, Ding ZP, Johan A, Lim YL (1998) Midterm angiographic outcome of single–vessel intracoronary stent placement in diabetic versus nondiabetic patients: a matched comparative study. Am Heart J 136(1):150–155

    Article  CAS  PubMed  Google Scholar 

  30. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS (2004) Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109(12):1497–1502

    CAS  PubMed  Google Scholar 

  31. Lee CD, Folsom AR, Pankow JS, Brancati FL (2004) Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 109(7):855–860

    Article  PubMed  Google Scholar 

  32. Legrand VM, Serruys PW, Unger F, van Hout BA, Vrolix MC, Fransen GM, Nielsen TT, Paulsen PK, Gomes RS, de Queiroz e Melo JM, Neves JP, Lindeboom W, Backx B (2004) Threeyear outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 109(9):1114–1120

    Article  PubMed  Google Scholar 

  33. Lemp GF, Vander Zwaag R, Hughes JP, Maddock V, Kroetz F, Ramanathan KB, Mirvis DM, Sullivan JM (1987) Association between the severity of diabetes mellitus and coronary arterial atherosclerosis. Am J Cardiol 60(13):1015–1019

    Article  CAS  PubMed  Google Scholar 

  34. Mak KH, Faxon DP (2003) Clinical studies on coronary revascularization in patients with type 2 diabetes. Eur Heart J 24(12):1087–1103

    PubMed  Google Scholar 

  35. Mehilli J, Kastrati A, Dirschinger J, Dotzer F, Pache J, Hausleiter J, Kramer W, Schuhlen H, Schomig A (2002) Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus. Am J Med 112(1):13–18

    Article  PubMed  Google Scholar 

  36. Mehilli J, Kastrati A, Schuhlen H, Dibra A, Dotzer F, von Beckerath N, Bollwein H, Pache J, Dirschinger J, Berger PP, Schomig A (2004) Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation 110(24):3627–3635

    Article  CAS  PubMed  Google Scholar 

  37. Moussa I, Leon MB, Baim DS, O’Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW (2004) Impact of sirolimus–eluting stents on outcome in diabetic patients: a SIRIUS (SIRol– ImUS–coated Bx Velocity balloon–expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109(19):2273–2278

    Article  CAS  PubMed  Google Scholar 

  38. Otsuka Y, Miyazaki S, Okumura H, Yasuda S, Daikoku S, Morii I, Sutani Y, Goto Y, Nonogi H (2000) Abnormal glucose tolerance, not small vessel diameter, is a determinant of long–term prognosis in patients treated with balloon coronary angioplasty. Eur Heart J 21(21):1790–1796

    Article  CAS  PubMed  Google Scholar 

  39. Savage MP, Fischman DL, Slota P (1997) Coronary intervention in the diabetic patient: improved outcome following stent implantation versus balloon angioplasty (abstract). J Am Coll Cardiol 29:188A

    Google Scholar 

  40. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule–1 (VCAM–1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96(3):1395–1403

    CAS  PubMed  Google Scholar 

  41. Schofer J, Schluter M, Rau T, Hammer F, Haag N, Mathey DG (2000) Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study. J Am Coll Cardiol 35(6):1554–1559

    Article  CAS  PubMed  Google Scholar 

  42. Sedlis SP, Morrison DA, Lorin JD, Esposito R, Sethi G, Sacks J, Henderson W, Grover F, Ramanathan KB, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Murphy E, Ward H, Miller L, Kiesz S, Barbiere C, Lewis D (2002) Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 40(9):1555–1566

    Article  PubMed  Google Scholar 

  43. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA (2001) Comparison of coronaryartery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344(15):1117–1124

    Article  CAS  PubMed  Google Scholar 

  44. Seyfer AE, Shriver CD, Miller TR, Graeber GM (1988) Sternal blood flow after median sternotomy and mobilization of the internal mammary arteries. Surgery 104(5):899–904

    CAS  PubMed  Google Scholar 

  45. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W (2005) Guidelines for percutaneous coronary interventions: the task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 26(8):804–847

    Article  PubMed  Google Scholar 

  46. Smith SC Jr, Faxon D, Cascio W, Schaff H, Gardner T, Jacobs A, Nissen S, Stouffer R (2002) Prevention conference VI: diabetes and cardiovascular disease: Writing Group VI: revascularization in diabetic patients. Circulation 105(18):e165–e169

    Article  PubMed  Google Scholar 

  47. Sobel BE, Frye R, Detre KM (2003) Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation 107(4):636–642

    Article  PubMed  Google Scholar 

  48. Srinivasan AK, Grayson AD, Fabri BM (2004) On–pump versus off–pump coronary artery bypass grafting in diabetic patients: a propensity score analysis. Ann Thorac Surg 78(5):1604–1609

    Article  PubMed  Google Scholar 

  49. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12–yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16(2):434–444

    CAS  PubMed  Google Scholar 

  50. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. Jama 288(19):2411–2420

    Article  CAS  PubMed  Google Scholar 

  51. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME (2004) Oneyear clinical results with the slow–release, polymer–based, paclitaxel–eluting TAXUS stent: the TAXUS–IV trial. Circulation 109(16):1942–1947

    Article  CAS  PubMed  Google Scholar 

  52. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME (2004) A polymerbased, paclitaxel–eluting stent in patients with coronary artery disease. N Engl J Med 350(3):221–231

    Article  CAS  PubMed  Google Scholar 

  53. Suselbeck T, Latsch A, Siri H, Gonska B, Poerner T, Pfleger S, Schumacher B, Borggrefe M, Haase KK (2001) Role of vessel size as a predictor for the occurrence of in–stent restenosis in patients with diabetes mellitus. Am J Cardiol 88(3):243–247

    CAS  PubMed  Google Scholar 

  54. Takagi T, Yamamuro A, Tamita K, Yamabe K, Katayama M, Mizoguchi S, Ibuki M, Tani T, Tanabe K, Nagai K, Shiratori K, Morioka S, Yoshikawa J (2003) Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study. Am Heart J 146(2):E5

    Article  PubMed  Google Scholar 

  55. Tschoepe D, Roesen P, Kaufmann L, Schauseil S, Kehrel B, Ostermann H, Gries FA (1990) Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest 20(2):166–170

    CAS  PubMed  Google Scholar 

  56. Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T, McFadden EP, Lablanche JM, Bertrand ME (1997) Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96(5):1454–1460

    CAS  PubMed  Google Scholar 

  57. Van Belle E, Perie M, Braune D, Chmait A, Meurice T, Abolmaali K, McFadden EP, Bauters C, Lablanche JM, Bertrand ME (2002) Effects of coronary stenting on vessel patency and long–term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 40(3):410–417

    Article  PubMed  Google Scholar 

  58. van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW (2002) The effect of completeness of revascularization on event–free survival at one year in the ARTS trial. J Am Coll Cardiol 39(4):559–564

    Article  PubMed  Google Scholar 

  59. Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, Deychak Y, Simoons ML, Califf RM, Topol EJ, Ross AM (1996) Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO–I experience. J Am Coll Cardiol 28(7):1661–1669

    CAS  PubMed  Google Scholar 

  60. Yue TL, Bao W, Gu JL, Cui J, Tao L, Ma XL, Ohlstein EH, Jucker BM (2005) Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion–induced myocardial injury. Diabetes 54(2):554–562

    CAS  PubMed  Google Scholar 

  61. Yumoto K, Kato KI, Doi H (2000) The influence of diabetic control on restenosis after coronary stenting (abstract). Circulation 102:II–730

    Google Scholar 

  62. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST–segment elevation. N Engl J Med 345(7):494–502

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kerckhoff-Klinik Bad Nauheim, Benekestraße 2–8, 61231, Bad Nauheim, Germany

    Albrecht Elsässer, Helge Möllmann, Holger M. Nef & Christian W. Hamm

Authors
  1. Albrecht Elsässer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helge Möllmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Holger M. Nef
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christian W. Hamm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albrecht Elsässer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elsässer, A., Möllmann, H., Nef, H.M. et al. How to revascularize patients with diabetes mellitus—. Clin Res Cardiol 95, 195–203 (2006). https://doi.org/10.1007/s00392-006-0365-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-006-0365-z

Key words

Search

Navigation